 Connection
Jay Portnoy to Administration, Intranasal
This is a "connection" page, showing publications Jay Portnoy has written about Administration, Intranasal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.097 |
|
|
|
-
Wallace DV, Dykewicz MS, Oppenheimer J, Portnoy JM, Lang DM. Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters. Ann Intern Med. 2017 Dec 19; 167(12):876-881.
Score: 0.040
-
Spector S, Wallace D, Nicklas R, Portnoy J, Blessing-Moore J, Bernstein D, Cox L, Oppenheimer J, Lang D, Schuller D, Randolph C, Tilles S, Khan D, Dykewicz M. Comments on Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. J Allergy Clin Immunol. 2011 Jun; 127(6):1641-2; author reply 1643-5.
Score: 0.025
-
Bernstein JA, Prenner B, Ferguson BJ, Portnoy J, Wheeler WJ, Sacks HJ. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis. Am J Rhinol Allergy. 2009 Sep-Oct; 23(5):512-7.
Score: 0.023
-
Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996 Dec; 17(12):811-3.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|